Follow-Up of Surgical or Nonsurgical Patients with Pulmonary Cryptococcosis: A Real-World Study

References

• Chang C, Sorrell T, Chen S. Pulmonary cryptococcosis. Semin Resp Crit Care. 2015;36(05):681–691. doi:10.1055/s-0035-1562895
   Web of Science ®Google Scholar
• Maliehe M, Ntoi MA, Lahiri S, et al.Cryptococcus neoformans environmental factors that contribute to the maintenance of pathogenesis. Microorganisms. 2020;8(2):180.
   PubMed Web of Science ®Google Scholar
• Yuchong C, Fubin C, Jianghan C, et al. Cryptococcosis in China (1985–2010): review of cases from Chinese database. Mycopathologia. 2012;173(5–6):329–335. doi:10.1007/s11046-011-9471-1
   PubMed Web of Science ®Google Scholar
• Denham S, Brown J. Mechanisms of pulmonary escape and dissemination by Cryptococcus neoformans. J Fungi. 2018;4(1):25. doi:10.3390/jof4010025
   Web of Science ®Google Scholar
• Wu SX, Guo NR, Li XF. Human pathogenic fungi in China – emerging trends from ongoing national survey for 1986, 1996, and 2006. Mycopathologia. 2011;171(6):387–393. doi:10.1007/s11046-011-9398-6
   Web of Science ®Google Scholar
• Liu YN, She DY, Sun TY, et al. [A multicentre retrospective study of pulmonary mycosis clinically proven from 1998 to 2007]. Zhonghua Jie He He Hu XI Za Zhi. 2011;34(2):86–90. Chinese.
   PubMedGoogle Scholar
• Li SS, Mody CH. Cryptococcus. Proc Am Thorac Soc. 2010;7(3):186–196. doi:10.1513/pats.200907-063AL
   Google Scholar
• Liao Y, Chen M, Hartmann T, Yang RY, Liao WQ. Epidemiology of opportunistic invasive fungal infections in China: review of literature. Chin Med J. 2013;126(2):361–368.
   Web of Science ®Google Scholar
• Ye F, Xie J-X, Zeng Q-S, Chen G-Q, Zhong S-Q, Zhong N-S. Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis. Lung. 2012;190(3):339–346. doi:10.1007/s00408-011-9362-8
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li N, Zhang Y. Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis. Eur Respir J. 2012;40(5):1191–1200. doi:10.1183/09031936.00168011
   PubMed Web of Science ®Google Scholar
• Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(3):291–322. doi:10.1086/649858
   PubMed Web of Science ®Google Scholar
• Taniwaki M, Yamasaki M, Ishikawa N, Kawamoto K, Hattori N. Pulmonary cryptococcosis mimicking lung cancer. Lancet Infect Dis. 2019;19(9):1033. doi:10.1016/S1473-3099(19)30278-6
   Web of Science ®Google Scholar
• Yang B, Lee H, Lee T, et al. The use of surgery in a real-world clinic to diagnose and treat pulmonary cryptococcosis in immunocompetent patients. J Thorac Dis. 2019;11(4):1251–1260. doi:10.21037/jtd.2019.04.17
   Web of Science ®Google Scholar
• Diseases ZMAS. Expert consensus on diagnosis and treatment of pulmonary cryptococcosis. Chin J Clin Infect Dis. 2017;10(5):321–326.
   Google Scholar
• Wei S, Su X, Pan YH, et al.Postoperative antifungal treatment of pulmonary cryptococcosis in non-HIV-infected and non-transplant-recipient patients: a report of 110 cases and literature review. Open Forum Infect Dis. 2020;7(1):a4.
   Web of Science ®Google Scholar
• Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S. Cryptococcosis in human immunodeficiency virus-negative patients. IJID. 2006;10(1):72–78. doi:10.1016/j.ijid.2004.12.004
   Web of Science ®Google Scholar
• Marr KA, Sun Y, Spec A. A multicenter, longitudinal cohort study of cryptococcosis in human immunodeficiency virus-negative people in the United States. Clin Infect Dis. 2020;70(2):252–261. doi:10.1093/cid/ciz193
   PubMed Web of Science ®Google Scholar
• Bandalizadeh Z, Javidnia J, Hosseini SA. Cryptococcus and cryptococcosis in Iran during 1969–2019: a systematic review and meta-analysis. J Mycol Med. 2020;30(1):100917. doi:10.1016/j.mycmed.2019.100917
   Web of Science ®Google Scholar
• Chen J, Varma A, Diaz MR, Litvintseva AP, Wollenberg KK, Kwon-Chung KJ. Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis. 2008;14(5):755–762. doi:10.3201/eid1405.071312
   PubMed Web of Science ®Google Scholar
• Roth GA, Abate D, Abate KH, et al.Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1684–1735. doi:10.1016/S0140-6736(18)31891-9
   Web of Science ®Google Scholar
• Zhou M, Wang H, Zeng X. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145–1158. doi:10.1016/S0140-6736(19)30427-1
   PubMed Web of Science ®Google Scholar
• Roberts NL, Mountjoy-Venning WC, Anjomshoa M, Banoub JA, Yasin YJ. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858. doi:10.1016/S0140-6736(18)32279-7
   Web of Science ®Google Scholar
• McFadden D, Zaragoza O, Casadevall A. The capsular dynamics of Cryptococcus neoformans. Trends Microbiol. 2006;14(11):497–505. doi:10.1016/j.tim.2006.09.003
   Web of Science ®Google Scholar
• Baddley JW, Perfect JR, Oster RA, et al. Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease. Eur J Clin Microbiol. 2008;27(10):937–943. doi:10.1007/s10096-008-0529-z
   Google Scholar
• Zhu T, Luo WT, Chen GH, et al. Extent of lung involvement and serum cryptococcal antigen test in non-human immunodeficiency virus adult patients with pulmonary cryptococcosis. Chin Med J. 2018;131(18):2210–2215. doi:10.4103/0366-6999.240815
   Web of Science ®Google Scholar
• Liu K, Ding H, Xu B. Clinical analysis of non-AIDS patients pathologically diagnosed with pulmonary cryptococcosis. J Thorac Dis. 2016;8(10):2813–2821. doi:10.21037/jtd.2016.10.36
   PubMed Web of Science ®Google Scholar
• La Hoz RM, Pappas PG. Cryptococcal infections: changing epidemiology and implications for therapy. Drugs. 2013;73(6):495–504. doi:10.1007/s40265-013-0037-z
   Web of Science ®Google Scholar
• Aberg JA, Mundy LM, Powderly WG. Pulmonary cryptococcosis in patients without HIV infection. Chest. 1999;115(3):734–740. doi:10.1378/chest.115.3.734
   PubMed Web of Science ®Google Scholar
• Davis MR, Nguyen MH, Donnelley MA, Thompson GR. Tolerability of long-term fluconazole therapy. J Antimicrob Chemoth. 2019;74(3):768–771. doi:10.1093/jac/dky501
   Web of Science ®Google Scholar
• Xu SX, Shen JL, Tang XF, Feng B, Xu HQ. Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis. Eur Rev Med Pharma. 2016;20(2):381–390.
   Web of Science ®Google Scholar